28 completed. 28 Phase 3, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 28 | Completed 28 |
| Phase 2 | 10 | Completed 10 |
Follow Paralysis: new trials by email Literature Review of Paralysis trials Research Report on Paralysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating drops - Blepharoptosis, Synkinesis | Phase 3 | Completed | Milton S. Hershey Medical Center | 36 | 2024-01-11 | 2026-03-09 |
| Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Completed | Vanda Pharmaceuticals | 17 | 2024-01-09 | 2026-10-19 |
| AMX0035 and Progressive Supranuclear Palsy AMX0035, Placebo - Progressive Supranuclear Palsy, PSP | Phase 2 / Phase 3 | Completed | Amylyx Pharmaceuticals Inc. | 139 | 2023-12-21 | 2026-04-30 |
| Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) Elamipretide, Placebo - Mitochondrial Myopathies, Mitochondrial Pathology | Phase 3 | Completed | Stealth BioTherapeutics Inc. | 102 | 2022-04-29 | 2025-10-24 |
| PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis PET/CT Scan with 11C-ER176, Core biopsy of gastric muscle - Diabetes, Gastroparesis With Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Mayo Clinic | 12 | 2021-05-10 | 2023-04-18 |
| A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD) | Phase 3 | Completed | GE Healthcare | 172 | 2020-06-28 | 2023-10-16 |
| Diaphragmatic Paralysis Comparison Between Local Anesthetic Volumen Doses After Interscalene Block Interscalene brachial plexus block, Levobupivacaine Hydrochloride 2.5 MG/ML - Diaphragmatic Paralysis, Brachial Plexus Block | Phase 3 | Completed | Instituto de Investigación Sanitaria Aragón | 48 | 2020-02-11 | 2022-08-12 |
| Interscalene Block and Dysfunction Diaphragmatic Ropivacaine 0.5% Injectable Solution, Ropivacaine 0.1% Injectable Solution - Diaphragmatic Paralysis | Phase 3 | Completed | University Hospital, Lille | 60 | 2019-10-29 | 2026-06-11 |
| Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis Tradipitant, Placebo, Open Label Tradipitant - Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Completed | Vanda Pharmaceuticals | 979 | 2019-08-20 | 2026-09-24 |
| Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis Placebo, Pimavanserin 34 mg, Pimavanserin 20 mg - Dementia-related Psychosis | Phase 3 | Completed | ACADIA Pharmaceuticals Inc. | 392 | 2017-09-27 | 2021-06-21 |
| Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy Rivastigmine, Placebo - Progressive Supranuclear Palsy (PSP) | Phase 3 | Completed | Assistance Publique Hopitaux De Marseille | 106 | 2016-07-26 | 2023-07-20 |
| Burke-Hocoma Efficiency Study Hocoma ArmeoSpring - Hemiparesis, Hemiplegia | Phase 3 | Completed | Burke Medical Research Institute | 47 | 2016-05-01 | 2022-10-04 |
| Fenofibrate Treatment in SCI Fenofibrate, No intervention - Spinal Cord Injury, Dyslipidemia | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 23 | 2015-05-18 | 2019-06-26 |
| Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Metoclopramide Nasal Spray, Placebo Nasal Spray - Diabetic Gastroparesis | Phase 3 | Completed | Evoke Pharma | 53 | 2014-04-01 | 2020-07-07 |
| Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Metoclopramide Nasal Spray, Placebo Nasal Spray - Diabetic Gastroparesis | Phase 3 | Completed | Evoke Pharma | 205 | 2014-03-27 | 2020-07-07 |
| Prucalopride Versus Placebo in Gastroparesis Prucalopride, Placebo - Gastroparesis, Diabetes Mellitus | Phase 2 / Phase 3 | Completed | University of Calgary | 15 | 2014-03-01 | 2020-10-08 |
| Static and Dynamic Postural Stability in Cerebral Palsy Children no distractor control group, visual and sound attentional distractors, sound attentional distractor alone - CP (Cerebral Palsy), Diplegia | Phase 3 | Completed | University Hospital, Grenoble | 24 | 2013-02-01 | 2016-03-23 |
| Sancuso® for Gastroparesis: An Open Label Study. Sancuso® - Gastroparesis | Phase 3 | Completed | Temple University | 14 | 2012-11-01 | 2021-05-26 |
| Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy Davunetide, Placebo - Progressive Supranuclear Palsy | Phase 2 / Phase 3 | Completed | Allon Therapeutics | 313 | 2010-10-01 | 2013-01-17 |
| MEOPA to Improve Physical Therapy Results After Multilevel Surgery MEOPA, Medicinal air - Cerebral Palsy, Spastic Diplegia | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 64 | 2008-03-01 | 2023-02-03 |
Showing 20 of 28. Sign in to see all of them.
Gastroparesis (8) · Supranuclear Palsy, Progressive (6) · Nausea (5) · Quadriplegia (5) · Spinal Cord Injuries (5) · Vomiting (5) · Diabetes Mellitus (4) · Hemiplegia (4) · Abdominal Pain (2) · Cerebral Palsy (2) · Facial Paralysis (2) · Respiratory Paralysis (2) · Stomach Diseases (2) · Alzheimer Disease (1) · Asthma (1)
Neurologic Manifestations (28) · Pathological Conditions, Signs and Symptoms (28) · Signs and Symptoms (28) · Nervous System Diseases (19) · Central Nervous System Diseases (14) · Brain Diseases (9) · Cranial Nerve Diseases (8) · Digestive System Diseases (8) · Eye Diseases (8) · Gastrointestinal Diseases (8) · Ocular Motility Disorders (7) · Ophthalmoplegia (7) · Basal Ganglia Diseases (6) · Metabolic Diseases (6)
NG-Nitroarginine Methyl Ester (2) · Electric Stimulation Therapy (1) · Fenofibrate (1) · Granisetron (1) · Injections (1) · Iodine-123 (1) · Levobupivacaine (1) · Meopa (1) · Methylprednisolone (1) · Oxymetazoline (1) · Rivastigmine (1) · Ropivacaine (1) · arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1) · coenzyme Q10 (1) · davunetide (1)
Assistance Publique - Hôpitaux de Paris (2) · Evoke Pharma (2) · US Department of Veterans Affairs (2) · VA Office of Research and Development (2) · Vanda Pharmaceuticals (2) · ACADIA Pharmaceuticals Inc. (1) · Allon Therapeutics (1) · Amylyx Pharmaceuticals Inc. (1) · Assistance Publique Hopitaux De Marseille (1) · Burke Medical Research Institute (1) · GE Healthcare (1) · Instituto de Investigación Sanitaria Aragón (1) · Lahey Clinic (1) · Mayo Clinic (1) · Milton S. Hershey Medical Center (1)
United States (18) · France (8) · Germany (5) · Spain (4) · Canada (3) · Italy (3) · United Kingdom (3) · Australia (2) · Belgium (1) · Bulgaria (1) · Chile (1) · China (1) · Czechia (1) · Hungary (1) · Netherlands (1)
Adam Boxer, M.D., PhD. (1) · Arthur Prochazka (1) · Charles Burgar, MD (1) · Christopher N Andrews, MD, MSc (1) · Diana Apetauerova, MD (1) · Henry P Parkman, MD (1)
PMID 17385265, PMID 17965289, PMID 19618698, PMID 19651280, PMID 20012982, PMID 21372246, PMID 21674393, PMID 21762873, PMID 21872708, PMID 23700789, PMID 24873720, PMID 28436538, PMID 28726270, PMID 32250331, PMID 33874993, PMID 34289275, PMID 34934801, PMID 37924856, PMID 38237696, PMID 38825840, PMID 41286676, PMID 42244823
2016 (1), 2017 (1), 2019 (1)